References
- Sanguinetti M, Posteraro B, Lass-Flörl C. Antifungal drug resistance among Candida species: mechanisms and clinical impact. Mycoses 2015;58:2–13
- Carradori S, Secci D, Bolasco A, et al. Synthesis and cytotoxicity of novel (thiazol-2-yl)hydrazine derivatives as promising anti-Candida agents. Eur J Med Chem 2013;65:102–11
- (a) Vandal J, Abou-Zaid MM, Ferroni G, Leduc LG. Antimicrobial activity of natural products from the flora of Northern Ontario, Canada. Pharm Biol 2015;53:800–6 (b) De Monte C, Bizzarri B, Gidaro MC, et al. Bioactive compounds of Crocus sativus L. and their semi-synthetic derivatives as promising anti-Helicobacter pylori, anti-malarial and anti-leishmanial agents. J Enzyme Inhib Med Chem 2015;30:1027–33
- Cavaleiro C, Salgueiro L, Gonçalves MJ, et al. Antifungal activity of the essential oil of Angelica major against Candida, Cryptococcus, Aspergillus and dermatophyte species. J Nat Med 2015;69:241–8
- Cannas S, Molicotti P, Usai D, et al. Antifungal, anti-biofilm and adhesion activity of the essential oil of Myrtus communis L. against Candida species. Nat Prod Res 2014;28:2173–7
- Rani N, Kumar P, Singh R, Sharma A. Molecular docking evaluation of imidazole analogues as potent Candida albicans 14α-demethylase inhibitors. Curr Comput Aided Drug Des 2015;11:8–20
- Jiang Z, Gu J, Wang C, et al. Design, synthesis and antifungal activity of novel triazole derivatives containing substituted 1,2,3-triazole-piperdine side chains. Eur J Med Chem 2014;82:490–7
- Xiao ZP, Wang XD, Wang PF, et al. Design, synthesis, and evaluation of novel fluoroquinolone-flavonoid hybrids as potent antibiotics against drug-resistant microorganisms. Eur J Med Chem 2014;80:92–100
- Wolber G, Langer T. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J Chem Inf Model 2005;45:160–9
- Secci D, Bizzarri B, Bolasco A, et al. Synthesis, anti-Candida activity, and cytotoxicity of new (4-(4-iodophenyl)thiazol-2-yl)hydrazine derivatives. Eur J Med Chem 2012;53:246–53
- Chimenti F, Bizzarri B, Bolasco A, et al. Synthesis and biological evaluation of novel 2,4-disubstituted-1,3-thiazoles as anti-Candida spp. agents. Eur J Med Chem 2011;46:378–82
- Chimenti F, Bizzarri B, Maccioni E, et al. Synthesis and in vitro activity of 2-thiazolylhydrazone derivatives compared with the activity of clotrimazole against clinical isolates of Candida spp. Bioorg Med Chem Lett 2007;17:4635–40
- (a) Chimenti F, Bolasco A, Secci D, et al. Investigations on the 2-thiazolylhydrazyne scaffold: synthesis and molecular modeling of selective human monoamine oxidase inhibitors. Bioorg Med Chem Lett 2010;18:5715–23 (b) D’Ascenzio M, Carradori S, Secci D, et al. Identification of the stereochemical requirements in the 4-aryl-2-cycloalkylidenhydrazinylthiazole scaffold for the design of selective human monoamine oxidase B inhibitors. Bioorg Med Chem 2014;22:2887–95 (c) Chimenti P, Petzer A, Carradori S, et al. Exploring 4-substituted-2-thiazolylhydrazones from 2-, 3-, and 4-acetylpyridine as selective and reversible hMAO-B inhibitors. Eur J Med Chem 2013;66:221–7 (d) Chimenti F, Secci D, Bolasco A, et al. Synthesis, stereochemical separation, and biological evaluation of selective inhibitors of human MAO-B: 1-(4-arylthiazol-2-yl)-2-(3-methylcyclohexylidene)hydrazines. J Med Chem 2010;53:6516–20
- Maestro, version 9.7. New York, NY: Schrödinger, LLC; 2014
- Mysinger MM, Carchia M, Irwin JJ, Shoichet BK. Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem 2012;55:6582–94
- Irwin JJ, Shoichet BK. ZINC – a free database of commercially available compounds for virtual screening. J Chem Inf Model 2005;45:177–82
- Canvas, version 2.2. New York, NY: Schrödinger, LLC; 2014
- LigPrep, version 2.9. New York, NY: Schrödinger, LLC; 2014
- Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;46:3–26
- Veber D, Johnson S, Cheng H, et al. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 2002;45:2615–23
- Walters W, Murcko M. Prediction of ‘drug-likeness’. Adv Drug Deliv Rev 2002;54:255–71
- National Committee for Clinical Laboratory Standard. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. 3rd ed. DM27-A3 vol. 28, n° 14. Wayne, PA: National Committee for Clinical Laboratory Standard; 2008
- De Monte C, Carradori S, Bizzarri B, et al. Anti-Candida activity and cytotoxicity of a large library of new N-substituted-1,3-thiazolidin-4-one derivatives. Eur J Med Chem 2016;107:82–96
- Shi Y, Zhou CH. Synthesis and evaluation of a class of new coumarin triazole derivatives as potential antimicrobial agents. Bioorg Med Chem Lett 2011;21:956–60
- Singh LK, Priyanka SV, Katiyar D. Design, synthesis and biological evaluation of some new coumarin derivatives as potential antimicrobial agents. Med Chem 2015;11:128–34
- Damu GL, Cui SF, Peng XM, et al. Synthesis and bioactive evaluation of a novel series of coumarinazoles. Bioorg Med Chem Lett 2014;24:3605–8
- Arshad A, Osman H, Bagley MC, et al. Synthesis and antimicrobial properties of some new thiazolyl coumarin derivatives. Eur J Med Chem 2011;46:3788–94
- Mladenović M, Vuković N, Sukdolak S, Solujić S. Design of novel 4-hydroxy-chromene-2-one derivatives as antimicrobial agents. Molecules 2010;15:4294–308
- Chimenti F, Carradori S, Secci D, et al. Synthesis and biological evaluation of novel conjugated coumarin–thiazole systems. J Heterocl Chem 2009;46:575–8
- Chai X, Yu S, Wang X, et al. Synthesis and antifungal activity of novel 7-O-substituted pyridyl-4-methyl coumarin derivatives. Med Chem Res 2013;22:4654–62